As of 2026-01-03, the Relative Valuation of Antibe Therapeutics Inc (ATE.TO) is (2.09) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.30 CAD, the upside of Antibe Therapeutics Inc based on Relative Valuation is -809.2%.
The range of the Relative Valuation is (1.67) - (5.01) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.7x - 14.4x | 5.9x |
| Forward P/E multiples | 4.7x - 14.1x | 5.9x |
| Fair Price | (1.67) - (5.01) | (2.09) |
| Upside | -667.4% - -1797.3% | -809.2% |
| Date | P/E |